inclusion criteria: have completed two doses of sinopharm, astrazeneca or sputnik vaccines with the recommended schedule 6 months prior to the date of enrolment willing and able to give written informed consent aged 18 years or above willing to complete the follow-up requirements of the study

inclusion criteria: have completed two doses of sinopharm, astrazeneca or sputnik vaccines with the recommended schedule 6 months prior to the date of enrolment willing and able to give written informed consent aged 18 years or above willing to complete the follow-up requirements of the study

inclusion criteria: have completed two doses of sinopharm or astrazeneca vaccines with the recommended schedule 6 months prior to the date of enrolment willing and able to give written informed consent aged 18 years or above willing to complete the follow-up requirements of the study

inclusion criteria: have completed two doses of sinopharm or astrazeneca vaccines with the recommended schedule 6 months prior to the date of enrolment willing and able to give written informed consent aged 18 years or above willing to complete the follow-up requirements of the study